Drug Royalty Corporation Inc.
|
|||
| Mailing Address: | Royal Bank Plaza, Suite 3120 South Tower, Box 122, 200 Bay Street Toronto, Ontario M5J 2J3 |
Head Office Address: | Royal Bank Plaza, Suite 3120 South Tower, Box 122, 200 Bay Street Toronto, Ontario M5J 2J3 |
| Contact Name: | James R. Webster, Executive Vice-President, Chief Financial Officer and Secretary Treasurer | Principal Regulator: | No filing is or has previously been made under the MRRS Prospectus Policy |
| Business e-mail address: | Short Form Prospectus Issuer: | No | |
| Telephone Number: | 416 863-1865 | Reporting Jurisdictions: | Ceased Reporting |
| Fax Number: | 416 863-5161 | Stock Exchange: | TSX |
| Date of Formation: | Mar 23 1993 | Stock Symbol: | |
| Jurisdiction Where Formed: | Canada | Auditor: | PricewaterhouseCoopers LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | N/A |
| CUSIP Number: | 26223T | Transfer Agent: | Computershare Trust Company of Canada |
| Financial Year-End: | Aug 31 | Size of Issuer (Assets): | $25,000,001 to $100,000,000 |
|
